Checkpoint Inhibitors – Page 2 – Asian Scientist Magazine

checkpoint inhibitors

Tasuku Honjo has made two groundbreaking discoveries in the field of immunotherapy—the well-earned fruits of a 50-year-long career.

A genetic alteration that allows cancer cells to evade attack could indicate if expensive antibody treatments are effective for particular patients.

Ovarian cancers resistant to existing treatments could be tackled using the PD-1 inhibitory antibody nivolumab, study shows.

Professors Tasuku Honjo and James P. Allison share the inaugural Tang Prize in Biopharmaceutical Sciences, Asia's Nobel Prize equivalent.

EDITOR’S PICK

10 Years Of Celebrating Asia’s Researchers

Every year, Asian Scientist Magazine publishes Asian Scientist 100, a carefully curated list of the best and brightest researchers and leaders in SETM in Asia. This year we complete a decade of doing so.
Learning From Environmental Defenders

Drawing on traditional knowledge systems, environmental researchers and policymakers in Asia are working with indigenous communities to design better strategies for environmental conservation.
The Equalizers

Across Asia, people with disabilities are breaking physical and social barriers to STEM fields, opening the way for others.